Current
$21.5B
5-Year Average
$47.3B
All-Time High
$209B
All-Time Low
$4.03B
Market cap daily chart for Moderna (MRNA)
Aug 2, 2021 – Jul 29, 2026 · 1,253 trading days
Market Cap growth chart for Moderna (MRNA) from 2018 to 2026
Latest: +87.6%
Market Cap history table for Moderna (MRNA) from 2018 to 2026
| 2026 | $21.5B | +87.6% | +$10.1B | ||
| 2025 | $11.5B | -28.2% | -$4.5B | ||
| 2024 | $16B | -58.0% | -$22B | ||
| 2023 | $38B | -49.2% | -$36.7B | ||
| 2022 | $74.7B | -31.7% | -$34.7B | ||
| 2021 | $109B | +174.8% | +$69.6B | ||
| 2020 | $39.8B | +515.7% | +$33.4B | ||
| 2019 | $6.47B | +28.9% | +$1.45B | ||
| 2018 | $5.02B | — | — |
- 2026$21.5B+87.6%
- 2025$11.5B-28.2%
- 2024$16B-58.0%
- 2023$38B-49.2%
- 2022$74.7B-31.7%
- 2021$109B+174.8%
- 2020$39.8B+515.7%
- 2019$6.47B+28.9%
- 2018$5.02B—
Market Cap values are taken from Moderna's reported income statements (share counts) and end-of-day prices (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Market Cap at Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's latest reported market cap is $20.1B. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
In 2026, Moderna (MRNA) market cap totalled $21.5B – surged 87.6% year-over-year.
Moderna market cap has contracted on net over the period, with a -27.8% compound annual growth rate over 2021–2026 (5 years).
Moderna market cap plunged from $109B in 2021 to $21.5B in 2026, a 80.3% drawdown.
Across the available history, market cap reached its high of $109B in 2021 and its low of $5.02B in 2018.
Moderna Market Cap by Year
Moderna Market Cap 2026: $21.5B
In 2026, Moderna reported market cap of $21.5B, surged 87.6% from 2025.
Moderna Market Cap 2025: $11.5B
Moderna market cap in 2025 was $11.5B, declined 28.2% below 2024.
Moderna Market Cap 2024: $16B
2024's market cap for Moderna came in at $16B, plunged 58.0% below 2023.
Moderna Market Cap 2023: $38B
Moderna posted market cap of $38B in 2023, plunged 49.2% below 2022.
Moderna Market Cap 2022: $74.7B
Moderna market cap in 2022 was $74.7B.
See more financial history for Moderna (MRNA).
Sector peers by Market Cap
Healthcare peers of Moderna (MRNA), ranked by their latest market cap
| $1.14T | |
| $640B | |
| $466B | |
| $382B | |
| $322B | |
| $229B | |
| $214B | |
| $209B |
- $1.14T
- $466B
- $322B
- $229B
- $209B
Frequently asked questions
Test yourself on MRNA
Market Cap — 10 rounds, every one of them MRNA against another company. Leave whenever you like.
Practice run — it doesn’t move your skill rating and doesn’t touch the leaderboards. Misses do go into your review queue.
Moderna (MRNA) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
How this company returns cash to shareholders — buybacks, dividends, and stock splits.